 |
|
Imitating monkey's 'jumping genes' could lead to new treatments for HIV
February 19, 2008UCL (University College London) scientists have taken a significant step in understanding how retroviruses such as HIV can move between species and the biological mechanisms behind the 'jumping genes' which make some monkeys immune. They will now use this knowledge to develop a gene therapy treatment for HIV/AIDS in humans.
The international team of researchers, coordinated by Professor Greg Towers, UCL Infection and Immunity, and funded by the Wellcome Trust, have identified a combination of genes in a species of monkey that protects against retroviruses - a particularly opportunistic family of viruses that can integrate into the host's genome and replicate as part of the cell's DNA. The team's findings are published today in Proceedings of the National Academy of Sciences (PNAS).
Professor Towers explained: "HIV causes AIDS and affects around 40 million people worldwide. Research has shown that HIV entered the human population from a chimpanzee retrovirus called SIV early in the 20th century. In order for a virus to successfully cross the species barrier and jump into a new species, it first has to bypass the new host's innate immune system, mediated by a combination of genes and proteins. One such gene, called TRIM5, has been shown to protect certain species from retroviruses - but unfortunately the human TRIM5 gene does not protect against HIV infection."
The team found that a species of Asian monkey called Rhesus Macaques have a sophisticated 'antiviral arsenal' that can protect them against retroviruses. By closely examining TRIM5 in this species, they demonstrate that in some monkeys another gene called Cyclophilin has been joined to the TRIM5 gene, generating a TRIMCyp fusion.
Dr Sam Wilson, the paper's first author, said: "Cyclophilin is very good at grabbing viruses as they enter cells. By fusing Cyclophilin to TRIM5, a gene is made that is good at grabbing viruses and good at destroying them. This is the second time that this fusion has been identified - a TRIMCyp gene also exists in South American Owl Monkeys and, until now, this was thought to be an evolutionary one-off.
"This new research shows that a TRIMCyp has evolved independently in two separate species - it's like lightening has struck twice. It's a remarkable example of convergent evolution, where organisms independently evolve similar traits as a result of having to adapt to similar environments. It also highlights the evolutionary selection pressure that viruses like HIV can apply."
Professor Greg Towers explained further: "The discovery is a compelling example of how 'jumping genes' can shuffle an organism's genetic makeup, generating useful new genes, and it is an exciting possibility for novel treatments for HIV/AIDS.
"About 25 per cent of Rhesus Macaques have the TRIM5 and a TRIMCyp gene, greatly expanding their antiviral arsenal. The others have an immunity, based around TRIM5, that protects them against a different combination of viruses. The gene seems to be evolving to protect the individual species from a range of different virus sequences."
Professor Towers and his team now aim to develop humanised TRIMCyp that blocks HIV infection by artificially fusing human Cyclophilin and human TRIM5. Professor Towers said: "We can then introduce the TRIMCyp into stem cells, using gene therapy technologies, and the stem cells could repopulate the patient with blood cells that are immune to HIV. This work, already underway, could offer a real possibility of novel treatments for HIV/AIDS."
University College London
The team found that a species of Asian monkey called Rhesus Macaques have a sophisticated 'antiviral arsenal' that can protect them against retroviruses. By closely examining TRIM5 in this species, they demonstrate that in some monkeys another gene called Cyclophilin has been joined to the TRIM5 gene, generating a TRIMCyp fusion.
Dr Sam Wilson, the paper's first author, said: "Cyclophilin is very good at grabbing viruses as they enter cells. By fusing Cyclophilin to TRIM5, a gene is made that is good at grabbing viruses and good at destroying them. This is the second time that this fusion has been identified - a TRIMCyp gene also exists in South American Owl Monkeys and, until now, this was thought to be an evolutionary one-off.
"This new research shows that a TRIMCyp has evolved independently in two separate species - it's like lightening has struck twice. It's a remarkable example of convergent evolution, where organisms independently evolve similar traits as a result of having to adapt to similar environments. It also highlights the evolutionary selection pressure that viruses like HIV can apply."
Professor Greg Towers explained further: "The discovery is a compelling example of how 'jumping genes' can shuffle an organism's genetic makeup, generating useful new genes, and it is an exciting possibility for novel treatments for HIV/AIDS.
"About 25 per cent of Rhesus Macaques have the TRIM5 and a TRIMCyp gene, greatly expanding their antiviral arsenal. The others have an immunity, based around TRIM5, that protects them against a different combination of viruses. The gene seems to be evolving to protect the individual species from a range of different virus sequences."
Professor Towers and his team now aim to develop humanised TRIMCyp that blocks HIV infection by artificially fusing human Cyclophilin and human TRIM5. Professor Towers said: "We can then introduce the TRIMCyp into stem cells, using gene therapy technologies, and the stem cells could repopulate the patient with blood cells that are immune to HIV. This work, already underway, could offer a real possibility of novel treatments for HIV/AIDS."
University College London
Gene Therapy Current Events and Gene Therapy News RSSThe Structure of the Mre11 Protein Bound to DNA
Repairing breaks in the two strands of the DNA double helix is critical for avoiding cancer. In humans and other organisms, a molecular machine called the MRN complex is responsible for finding and signaling double-strand breaks (DSBs), then launching the error-free method of DNA repair called homologous recombination.
Researchers create first model for retina receptors
A team of scientists at the University of Oklahoma Health Sciences Center has created the first genetic research model for a microscopic part of the eye that when missing causes blindness. The research appears in a recent issue of the Journal of Biological Chemistry.
New approach to gene therapy may shrink brain tumors, prevent their spread
Massachusetts General Hospital (MGH) researchers are investigating a new approach to gene therapy for brain tumors - delivering a cancer-fighting gene to normal brain tissue around the tumor to keep it from spreading.
A new therapeutic option for human hepatocyte cancer
p53-impaired tumors may be particularly suitable to parvovirus H-1-induced therapy. Although the p53 deficiency in tumors may induce resistance to chemotherapeutic agents, this will not affect the tumor cell susceptibility to H-1 PV-induced oncolytic infections.
Genetic profile reveals susceptibility to cleft palate
For the first time, researchers from the University of Pittsburgh School of Dental Medicine have identified a series of genetic mutations that appear to be linked to significant risk for cleft palate and other dental abnormalities.
Safety study indicates gene therapy for blindness improves vision
All three people who received gene therapy at the University of Florida to treat a rare, incurable form of blindness have regained some of their vision, according to a paper published online today in Human Gene Therapy.
Previous claims of siRNA therapeutic effects called into question by report in human gene therapy
The many recent reports documenting the therapeutic efficacy of short interfering RNAs (siRNAs) in animal models of human disease may actually be describing non-specific therapeutic effects related to the ability of siRNA to activate an immune response, according to a paper in the September 2008 issue (Volume 19, Number 9) of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.
Study reveals how blood flow force prevents clogged arteries
Machines on cell surfaces, mechanical and lifeless as bed springs, protect blood vessels by responding to blood flow force, according to research published today in the Journal of Cell Biology.
UAB Anti-Cancer Research Featured in Scientific American
Scientific American magazine focused on two University of Alabama at Birmingham (UAB) Comprehensive Cancer Center researchers in a news story on experimental next-generation anti-cancer therapies.
Hydrogels provide scaffolding for growth of bone cells
Hyaluronic hydrogels developed by Carnegie Mellon University researchers may provide a suitable scaffolding to enable bone regeneration. The hydrogels, created by Newell Washburn, Krzysztof Matyjaszewski and Jeffrey Hollinger, have proven to encourage the growth of preosteoblast cells, cells that aid the growth and development of bone. Doctoral student Sidi Bencherif will present this research, Sunday, Aug. 17 at the 236th national meeting of the American Chemical Society in Philadelphia.
More Gene Therapy Current Events and Gene Therapy News Articles
 | The Ethics of Human Gene Therapy by LeRoy Walters, Julie Gage Palmer The authors of this absorbing new book describe the science of gene therapy in terms easily accessible to the non-specialist, and focus on the controversial ethical and public policy issues surrounding human interventions in human heredity. After a brief survey of the structure and functions of DNA, genes, and cells, Walters and Palmer discuss three major types of potential genetic intervention:... |
 | Gene Therapy (Special Topics in Biology Series) by Mary Colavito, Michael A. Palladino KEY MESSSAGE: Will gene therapy one day become the ultimate application of genetic technology? Gene Therapy, the newest booklet in the Special Topics in Biology Series, addresses this question by exploring gene therapy as a complex technology for delivering therapeutic genes as a way to treat and cure human genetic diseases. Author Mary Colavito provides an overview of the basic science... |
 | Altered Fates: Gene Therapy and the Retooling of Human Life by Jeff Lyon, Peter Gorner Seven years in the making, Altered Facts chronicles the saga of gene therapy, a medical revoultion unparalleled in human history. Pulitzer Prize winners Lyon and Gorner tell the story of the race to be the first in the field and they uncover the behind-the-scenes machinations and rivalries among the researchers at some of the world's leading medical... |
 | Suicide Gene Therapy: Methods and Reviews (Methods in Molecular Medicine) The first comprehensive review of both the theory and practice of suicide gene therapy. The authors cover all the major aspects of suicide gene therapy, including the design and use of vectors in gene transduction, various enzyme and prodrug systems, the mechanistic analysis of the bystander effect, the design and synthesis of prodrugs, immunological implications, and its clinical impact. They... |
 | Gene Therapy: Treating Disease by Repairing Genes (New Biology) by Joseph, Ph.D. Panno |
 | Gene Therapy (Health and Medical Issues Today) by Evelyn B. Kelly Every day, newspapers and television news programs present stories on the latest controversies over healthcare and medical advances, but they do not have the space to provide detailed background on the issues. Websites and weblogs provide information from activists and partisans intent on presenting their side of a story. But where can students - or even ordinary citizens - go to obtain unbiased,... |
 | Nonviral Vectors for Gene Therapy Gene transfer within humans has been an obstacle until about 10 years ago. At that time, it was found that viral vectors were effective carriers of "healthy genes" into patients' cells. The problem, however, was that viral vectors proved unnecessarily harmful to humans: subjects experienced inflamatory activity and negative immunological responses to the genes. Viral vectors were also unable to... |
 | Gene and Cell Therapy: Therapeutic Mechanisms and Strategies, Third Edition This latest edition of Gene and Cell Therapy provides comprehensive coverage of all aspects of the tools and state-of-the-art technologies that are currently available in this field. Written by international leaders, this third edition features 12 additional chapters that address such new topics as gene and cell therapies for diabetes and cardiovascular disease, relevant nanotechnologies, siRNA... |
 | Gene Therapy and Gene Delivery Systems (Advances in Biochemical Engineering / Biotechnology) |
 | Stem Cell and Gene-Based Therapy: Frontiers in Regenerative Medicine The inability of the human body to be able significantly to self repair injured organs and tissues results in a considerable medical and social problem. During the last few years there has been incredible progress, and the achievements in experimental strategies for tissue regeneration, particularly in cell transplantation and stem cell research, have led to potential treatment options for many... |
| © 2008 BrightSurf.com |